Florida Cancer Specialists Expands Bayfront Presence with Orlando Health Collaboration

Event summary

  • Florida Cancer Specialists & Research Institute (FCS) opened a 31,000 square-foot facility in St. Petersburg, Florida, on February 13, 2026.
  • The new location is part of the Orlando Health Institute Square development.
  • The facility employs six medical oncologists and hematologists, supported by four advanced practice practitioners.
  • The clinic offers services including on-site PET/CT imaging, infusion chairs, and access to clinical trials and advanced therapies like bispecific treatments and cell therapy.

The big picture

This expansion reflects a broader trend of healthcare providers seeking to integrate specialized services with hospital systems to enhance patient access and care coordination. The investment in advanced therapies signals a commitment to staying at the forefront of oncology treatment, positioning FCS to compete for patients seeking cutting-edge care. The partnership with Orlando Health suggests a strategic move to leverage the hospital’s infrastructure and referral network to expand FCS’s reach within the Tampa Bay area.

What we're watching

Market Penetration
The success of this expansion hinges on FCS’s ability to capture market share in Pinellas County, given its existing presence of six other sites in the region; cannibalization of existing patient volume will be a key indicator.
Integration Risk
The collaborative model with Orlando Health requires seamless integration of workflows and data systems, and any friction could negatively impact patient outcomes and operational efficiency.
Therapy Adoption
The clinic’s investment in advanced therapies like cell therapy will require ongoing training and infrastructure upgrades, and the rate of patient adoption will determine the return on investment.